Our core content on Lung conditions and related factsheets has been translated to a number of other languages.
For more languages explore all available Factsheet translations.
Volunteer as a translator or learn how to translate using Chrome, Firefox or Edge browsers.
Our core content on Lung conditions and related factsheets has been translated to a number of other languages by our volunteer team.
For more languages explore all available Factsheet translations.
Volunteer as a translator or learn how to translate using Chrome, Firefox or Edge browsers.
Researchers have found that lung development during the first 28 days of life is important to the immune system’s ability to defend the body against allergic reactions in adulthood.
Scientists understand that the development of allergies is likely to be linked to lung development in early life, however little is known about the process behind this.
The study, published in the journal, Nature Medicine, examined tiny cells in the lungs, known as microbiota, and looked at the role they play in the development of allergies.
The researchers observed lung growth and allergies in young mice. They found that, when exposed to dust mites immediately after birth, the mice had an allergic reaction.
When the mice came into contact with the dust mites after two weeks of development, during which the number of microbiota in the lungs grew, the level of reaction was reduced. The researchers also found that if they prevented the growth of microbiota in the lungs, the mice were also more prone to allergies later in life.
The findings suggest that microbiota play a key role in the development of allergies, and need further investigation to understand whether this could be a target for treatment in the future.
Sign up to our free monthly newsletter to get the latest information and research news on lung conditions, plus views from experts and patients! You can unsubscribe at any time.
ELF is a non-profit organisation registered as a UK company (VAT no. GB 115 0027 74) and charity (no. 1118930).
Our Brussels office enterprise number is 0738.383.695
European Lung Foundation's TR ID number in the Transparency Register is: 094039644810-79
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.
Advertisement cookies are used to provide visitors with relevant ads and marketing campaigns. These cookies track visitors across websites and collect information to provide customized ads.
No description